The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 25, 2017

Filed:

Jul. 01, 2008
Applicants:

Mark Puder, Medfield, MA (US);

Kathleen M. Gura, Norfolk, MA (US);

Inventors:

Mark Puder, Medfield, MA (US);

Kathleen M. Gura, Norfolk, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/20 (2006.01); A61K 31/23 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 31/202 (2006.01); A23L 33/00 (2016.01); A23L 33/12 (2016.01);
U.S. Cl.
CPC ...
A61K 31/23 (2013.01); A23L 33/12 (2016.08); A23L 33/40 (2016.08); A61K 9/0029 (2013.01); A61K 9/107 (2013.01); A61K 31/202 (2013.01);
Abstract

The present invention is based on the discovery that parenteral nutrition (PN) induced liver disease, e.g. fatty liver disease, can be prevented and even reversed by administration of primarily omega-3-fatty acid with PN rather than the administration of the standard intravenous lipid emulsions that contain primarily plant derived omega-6 fatty acid. Thus, the present invention provides a method for treating or preventing liver disease in a human patient obtaining nutritional support through PN. The method comprises intravenous administration of an effective amount of an omega-3-fatty acid emulsion to the patient, wherein the patient is not administered phytosterols or plant derived fatty acids, e.g. omega-6 fatty acids derived from a plant source, and wherein the administration of the omega-3-fatty acid emulsion to the patient is for a period greater than three weeks. Preferably, the administration is for a period of greater than six weeks. More preferably, the administration is for a period greater than three months.


Find Patent Forward Citations

Loading…